UNSPSC 51292400: Antidepressant benzene derivatives

Antidepressant drugs made from a toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation.

UNSPSC 51292400 Antidepressant benzene derivatives is a Class code that in practice encompasses pharmaceutical supply, drug distribution systems, and pharmacy benefit program administration for state and local health agencies and cooperative purchasing organizations. State and local governments use this code to procure not only antidepressants but also emergency medicines such as naloxone, over-the-counter pharmaceuticals, and related drug deactivation or safe-disposal systems to support public health initiatives, employee health plans, and community health programs. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions. Recent solicitations show county governments and state agencies sourcing directly from manufacturers and authorized wholesalers to supply community health facilities and government employee pharmacy benefit programs.

Activity under the code spans Florida, Texas, and Minnesota, with representation through direct procurement and cooperative purchasing mechanisms. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to its community health building, with contracts structured for a two-year initial term and optional one-year renewal. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program aimed at direct contracting between state pharmacy benefit programs and manufacturers outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026 (response due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and over-the-counter products distributed through three authorized wholesalers to participating state and local government facilities in Minnesota and Oregon, with pricing weighted at 75 percent of evaluation criteria and contract terms beginning July 1, 2026.